INVESTABOT
Equity Research
XNYS · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: HCA Healthcare earned $7.15 per diluted share in Q1 2026, up 10.9% from $6.45 a year ago, on revenue of $19.1B — a 4.3% increase from $18.3B in Q1 2025.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/7/2026 | Marks Mike A | EVP and CFO | GIFT | -3,336 | — | — |
| 5/7/2026 | Marks Mike A | EVP and CFO | GIFT | 3,336 | — | — |
| 4/28/2026 | Frist William R | — | GRANT | 809 | — | — |
| 4/28/2026 | FRIST THOMAS F III | — | GRANT | 1,041 | — | — |
| 4/28/2026 | Smith Andrea B | — | GRANT | 509 | — | — |
| 4/28/2026 | Riley Wayne Joseph | — | GRANT | 509 | — | — |
| 4/28/2026 | MICHELSON MICHAEL W | — | GRANT | 925 | — | — |
| 4/28/2026 | Johnston Hugh F | — | GRANT | 809 | — | — |
| 4/28/2026 | DEPARLE NANCY ANN | — | GRANT | 509 | — | — |
| 4/28/2026 | CHIDSEY JOHN | — | GRANT | 809 | — | — |
| 2/18/2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | SELL | -1,694 | $533 | $903,537 |
| 2/13/2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | OPTION_EXERCISE | 5,000 | $237 | $1,183,050 |
| 2/13/2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | TAX_WITHHOLD | -3,306 | $540 | $1,786,199 |
| 2/13/2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | OPTION_EXERCISE | -5,000 | — | — |
| 2/11/2026 | Wyatt Christopher F. | SVP & Controller | SELL | -4,000 | $505 | $2,020,000 |
| 2/11/2026 | Berres Jennifer | SVP & Chief Human Res. Officer | SELL | -4,010 | $503 | $2,017,030 |
| 2/10/2026 | Wyatt Christopher F. | SVP & Controller | GRANT | 3,350 | — | — |
| 2/10/2026 | Wyatt Christopher F. | SVP & Controller | TAX_WITHHOLD | -1,034 | $502 | $519,120 |
| 2/10/2026 | Rossitto Erica | SVP & Chief Nurse Executive | GRANT | 1,676 | — | — |
| 2/10/2026 | Rossitto Erica | SVP & Chief Nurse Executive | TAX_WITHHOLD | -418 | $502 | $209,857 |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 14,716,173 | $6,870,392,526 | — | 1/29/2026 |
| BlackRock | 13,363,266 | $6,324,032,318 | 6.2% | 5/13/2026 |
| BlackRock | 12,581,087 | $5,873,606,176 | — | 2/12/2026 |
| BlackRock | 13,003,600 | $5,069,973,824 | -2.7% | 8/7/2026 |
| BlackRock | 14,851,825 | $4,771,594,349 | — | 8/13/2024 |
| State Street | 7,539,550 | $3,568,016,642 | -0.4% | 5/15/2026 |
| State Street | 7,566,643 | $3,532,562,951 | — | 2/13/2026 |
| State Street | 7,469,035 | $2,912,102,056 | -0.9% | 8/7/2026 |
| Fidelity (FMR) | 4,401,023 | $2,082,740,406 | 14.8% | 5/15/2026 |
| Fidelity (FMR) | 3,833,373 | $1,789,648,890 | — | 2/17/2026 |
| JP Morgan Chase | 2,461,975 | $1,151,786,448 | 2.6% | 5/13/2026 |
| JP Morgan Chase | 2,399,220 | $1,120,100,169 | — | 2/11/2026 |
| Morgan Stanley | 2,294,880 | $1,086,030,791 | 4.6% | 5/15/2026 |
| Morgan Stanley | 2,194,522 | $1,024,535,446 | — | 5/27/2026 |
| Goldman Sachs | 2,139,172 | $1,012,341,599 | 20.7% | 5/15/2026 |
| Morgan Stanley | 2,586,771 | $1,008,556,857 | 12.7% | 8/13/2026 |
| Goldman Sachs | 2,467,414 | $962,020,140 | 15.3% | 8/14/2026 |
| JP Morgan Chase | 2,296,132 | $900,841,954 | -6.7% | 8/12/2026 |
| Goldman Sachs | 1,772,343 | $827,436,345 | — | 3/25/2026 |
| Fidelity (FMR) | 1,632,520 | $636,503,475 | -62.9% | 8/13/2026 |